Developing selectively nonselective drugs for treating CNS disorders
- 28 February 2007
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today: Therapeutic Strategies
- Vol. 3 (4), 413-419
- https://doi.org/10.1016/j.ddstr.2006.11.009
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Fixed-Drug Combinations as First-Line Treatment for HypertensionProgress in Cardiovascular Diseases, 2006
- Duloxetine Efficacy for Major Depressive Disorder in Male vs. Female PatientsThe Journal of Clinical Psychiatry, 2006
- Drug discovery: selecting the optimal approachDrug Discovery Today, 2006
- Progress towards better understanding and treatment of major psychiatric illnessesDrug Discovery Today, 2005
- 5-HT6 receptors: a novel target for cognitive enhancementPharmacology & Therapeutics, 2005
- Treatment for Adult HIV InfectionJAMA, 2004
- Psychiatry in the Genomics EraAmerican Journal of Psychiatry, 2003
- Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelinesJournal of Psychopharmacology, 2000
- Schizophrenia and L-745, 870, a novel dopamine D4 receptor antagonistTrends in Pharmacological Sciences, 1997
- Current advances and trends in the treatment of depressionTrends in Pharmacological Sciences, 1994